DigestRedComo funciona
Red
/
Empresas
Au
No verificado

Augurex Life Sciences Corp.

Sobre qué escribimos

BiotecnologíaCienciaIndustriaSaludSanidad

9 Comunicados de prensa

Ver todos los comunicados de prensa
17/11/2025
Sanidad
Biotecnología
Salud
Mercado laboral
Industria
Augurex Life Sciences Corp. Announces the Launch of the 14-3-3eta Test for Rheumatoid Arthritis Diagnosis and Monitoring with Sonic Reference Laboratory
Fuente
Augurex Life Sciences Corp.
Editor
Business Wire
1.00
0
28/10/2025
Industria
Salud
Higiene alimentaria
Ciencia
Farmacéutica
Biotecnología
Augurex Life Sciences Granted FDA Breakthrough Designation for SPINEstat®, its First-in-Class Diagnostic Test for Axial Spondyloarthritis
Fuente
Augurex Life Sciences Corp.
Editor
Business Wire
1.00
0
15/10/2025
Ciencia
Biotecnología
Tecnología
Salud
Técnica
Mercado laboral
Industria
Augurex Announces Expansion of Availability of the JOINTstat® Diagnostic Test for Rheumatoid Arthritis with MitogenDx
Fuente
Augurex Life Sciences Corp.
Editor
Business Wire
1.00
0
16/04/2025
Industria
Biotecnología
Técnica
Salud
Sanidad
Ciencia
Tecnología
Material médico sanitario
Augurex Secures Health Canada Approval for SPINEstat™, a First-in-Class Diagnostic Blood Test for Axial Spondyloarthritis
Fuente
Augurex Life Sciences Corp.
Editor
Business Wire
1.00
0
15/11/2024
Biotecnología
Farmacéutica
Salud
Mercado laboral
Augurex Life Sciences and Quest Diagnostics Collaborate to Improve Rheumatoid Arthritis Diagnosis and Management
Fuente
Augurex Life Sciences Corp.
Editor
Business Wire
1.00
0
13/11/2024
Técnica
Ciencia
Tecnología
Biotecnología
Sanidad
Salud
Mercado laboral
Industria
Augurex and New Day Diagnostics Announce Launch of Anti-14-3-3eta Multiplex Analyte Specific Reagents; Enabling a First-In-Class Diagnostic Test for Axial Spondyloarthritis
Fuente
Augurex Life Sciences Corp.
Editor
Business Wire
1.00
0
07/11/2024
Eventos
Industria
Técnica
Ciencia
Material médico sanitario
Tecnología
Biotecnología
Sanidad
Salud
Augurex to Present Axial Spondyloarthritis Data and Exhibit at ACR Convergence 2024 in Washington, DC
Fuente
Augurex Life Sciences Corp.
Editor
Business Wire
1.00
0
21/10/2024
Mercado laboral
Industria
Técnica
Ciencia
Material médico sanitario
Tecnología
Biotecnología
Salud
Sanidad
Augurex Announces Agreement with ARUP Laboratories to Expand Access to Advanced Rheumatoid Arthritis Diagnosis with the Launch of 14-3-3η (eta) Test
Fuente
Augurex Life Sciences Corp.
Editor
Business Wire
1.00
0
06/08/2024
Ciencia
Material médico sanitario
Sanidad
Salud
Mercado laboral
Augurex Life Sciences Corp. Names Healthcare Leader Neil Klompas to Succeed Co-Founder Dr. Norma Biln as President and CEO
Fuente
Augurex Life Sciences Corp.
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0